Departamento
CIENCIAS FARMACÉUTICAS
Publicaciones (46) Publicaciones en las que ha participado algún/a investigador/a
2023
-
A new host-targeted antiviral cyclolignan (SAU-22.107) for Dengue Virus infection in cell cultures. Potential action mechanisms based on cell imaging
Virus Research, Vol. 323
-
Antileishmanial Activity and In Silico Molecular Docking Studies of Malachra alceifolia Jacq. Fractions against Leishmania mexicana Amastigotes
Tropical Medicine and Infectious Disease, Vol. 8, Núm. 2
-
Antiplasmodial activity, structure-activity relationship and studies on the action of novel benzimidazole derivatives
Scientific reports, Vol. 13, Núm. 1, pp. 285
-
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis
CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320
-
Computational Structural Revision of Elaeophorbate and Other Triterpenoids with the Help of NAPROC-13. A New Strategy for Structural Revision of Natural Products
Journal of Natural Products, Vol. 86, Núm. 4, pp. 897-908
-
Detección de síntomas asociados a trastornos depresivos desde la farmacia comunitaria
Ars pharmaceutica, Vol. 64, Núm. 1, pp. 80-80
-
Diseño y desarrollo de una crema pañal con leche de burra
Farmajournal, Vol. 8, Núm. 1, pp. 21-31
-
Efectos adversos de la interacción triple whammy detectados en un servicio de urgencias hospitalario
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 35, Núm. 5, pp. 394-396
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
-
El reto formativo en enfermedades infecciosas: análisis de los Másteres Oficiales en España
REDU: Revista de Docencia Universitaria, Vol. 21, Núm. 2
-
Enhancement of Tumor Cell Immunogenicity and Antitumor Properties Derived from Platinum-Conjugated Iron Nanoparticles
Cancers, Vol. 15, Núm. 12
-
Evaluation of Two Osmosis-Based Methods for the Preparation of Drug Delivery Systems Based on Red Blood Cells
Pharmaceutics, Vol. 15, Núm. 9
-
Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project
Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115
-
Formulación y optimización de nanopartículas lipídicas con chitosán para la administración de quercetina
Farmajournal, Vol. 8, Núm. 2, pp. 17-25
-
Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition
International Journal of Molecular Sciences, Vol. 24, Núm. 24
-
GuaB3, an overlooked enzyme in cyanobacteria's toolbox that sheds light on IMP dehydrogenase evolution
Structure, Vol. 31, Núm. 12, pp. 1526-1534.e4
-
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series
Journal of Crohn's and Colitis, Vol. 17, Núm. 5, pp. 722-727
-
Importancia de las interacciones alimentos-medicamentos. Propuesta de un procedimiento de trabajo dentro del Servicio de Seguimiento Farmacoterapéutico
Ars pharmaceutica, Vol. 64, Núm. 1, pp. 40-40
-
Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells
Pharmaceutics, Vol. 15, Núm. 3
-
In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis
European Journal of Medicinal Chemistry, Vol. 258